ll2 llc1 cell line Search Results


99
ATCC lewis lung carcinoma llc1 cells
Lewis Lung Carcinoma Llc1 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lewis lung carcinoma llc1 cells/product/ATCC
Average 99 stars, based on 1 article reviews
lewis lung carcinoma llc1 cells - by Bioz Stars, 2026-04
99/100 stars
  Buy from Supplier

96
ATCC mouse lung carcinoma llc1
Mouse Lung Carcinoma Llc1, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse lung carcinoma llc1/product/ATCC
Average 96 stars, based on 1 article reviews
mouse lung carcinoma llc1 - by Bioz Stars, 2026-04
96/100 stars
  Buy from Supplier

94
ATCC luciferase ll 2 llc1 luc2
Luciferase Ll 2 Llc1 Luc2, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/luciferase ll 2 llc1 luc2/product/ATCC
Average 94 stars, based on 1 article reviews
luciferase ll 2 llc1 luc2 - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier

90
iCell Gene Therapeutics lung cancer cell line ll/2 (llc1)
Lung Cancer Cell Line Ll/2 (Llc1), supplied by iCell Gene Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lung cancer cell line ll/2 (llc1)/product/iCell Gene Therapeutics
Average 90 stars, based on 1 article reviews
lung cancer cell line ll/2 (llc1) - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

94
ATCC lewis lung carcinoma ll2 llc1 mouse cells
Lewis Lung Carcinoma Ll2 Llc1 Mouse Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lewis lung carcinoma ll2 llc1 mouse cells/product/ATCC
Average 94 stars, based on 1 article reviews
lewis lung carcinoma ll2 llc1 mouse cells - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier

99
ATCC lewis lung carcinoma cell line ll 2 llc1
Lewis Lung Carcinoma Cell Line Ll 2 Llc1, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lewis lung carcinoma cell line ll 2 llc1/product/ATCC
Average 99 stars, based on 1 article reviews
lewis lung carcinoma cell line ll 2 llc1 - by Bioz Stars, 2026-04
99/100 stars
  Buy from Supplier

99
ATCC enh204 fp rrid cvcl b288 b16 f10 atcc cat crl 6475 rrid cvcl 0159 ll 2
Enh204 Fp Rrid Cvcl B288 B16 F10 Atcc Cat Crl 6475 Rrid Cvcl 0159 Ll 2, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/enh204 fp rrid cvcl b288 b16 f10 atcc cat crl 6475 rrid cvcl 0159 ll 2/product/ATCC
Average 99 stars, based on 1 article reviews
enh204 fp rrid cvcl b288 b16 f10 atcc cat crl 6475 rrid cvcl 0159 ll 2 - by Bioz Stars, 2026-04
99/100 stars
  Buy from Supplier

95
ATCC ll2 llc1 cell line
Ll2 Llc1 Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ll2 llc1 cell line/product/ATCC
Average 95 stars, based on 1 article reviews
ll2 llc1 cell line - by Bioz Stars, 2026-04
95/100 stars
  Buy from Supplier

90
BioResource International Inc mouse lewis lung carcinoma cell line llc1 (ll/2)
IDO shRNA and D-1MT treatment inhibits <t>LLC1</t> tumor growth and causes increasing number of tumor-infiltrating neutrophils in a subcutaneous lung tumor model. ( a ) Experimental design. 2 × 10 5 LLC1 cells were subcutaneously injected into male inbred C57BL/6JNarl mice. Scramble IDO shRNA (Scr IDOsh), IDO shRNA (IDO sh), and 1-methyl-D-tryptophan (D-1MT) was treated on 7 days after LLC1 injection. ( b ) Tumor growth curve. *A statistically significant difference when compared with scramble IDO shRNA group on 16 days after LLC1 injection ( P < 0.05). ( c ) Number of tumor-infiltrated CD11b + Ly6G + neutrophils. *A statistically significant difference when compared with scramble IDO shRNA group ( P < 0.05). ( d ) Number of CD11b + Ly6G + neutrophils in spleen at 16 days after LLC1 injection. IDO, Indoleamine 2,3-dioxygenase; shRNA, short hairpin RNA.
Mouse Lewis Lung Carcinoma Cell Line Llc1 (Ll/2), supplied by BioResource International Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse lewis lung carcinoma cell line llc1 (ll/2)/product/BioResource International Inc
Average 90 stars, based on 1 article reviews
mouse lewis lung carcinoma cell line llc1 (ll/2) - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Charles River Laboratories ll/2 (llc1) tumors
IDO shRNA and D-1MT treatment inhibits <t>LLC1</t> tumor growth and causes increasing number of tumor-infiltrating neutrophils in a subcutaneous lung tumor model. ( a ) Experimental design. 2 × 10 5 LLC1 cells were subcutaneously injected into male inbred C57BL/6JNarl mice. Scramble IDO shRNA (Scr IDOsh), IDO shRNA (IDO sh), and 1-methyl-D-tryptophan (D-1MT) was treated on 7 days after LLC1 injection. ( b ) Tumor growth curve. *A statistically significant difference when compared with scramble IDO shRNA group on 16 days after LLC1 injection ( P < 0.05). ( c ) Number of tumor-infiltrated CD11b + Ly6G + neutrophils. *A statistically significant difference when compared with scramble IDO shRNA group ( P < 0.05). ( d ) Number of CD11b + Ly6G + neutrophils in spleen at 16 days after LLC1 injection. IDO, Indoleamine 2,3-dioxygenase; shRNA, short hairpin RNA.
Ll/2 (Llc1) Tumors, supplied by Charles River Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ll/2 (llc1) tumors/product/Charles River Laboratories
Average 90 stars, based on 1 article reviews
ll/2 (llc1) tumors - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

b16-f1  (ATCC)
97
ATCC b16-f1
IDO shRNA and D-1MT treatment inhibits <t>LLC1</t> tumor growth and causes increasing number of tumor-infiltrating neutrophils in a subcutaneous lung tumor model. ( a ) Experimental design. 2 × 10 5 LLC1 cells were subcutaneously injected into male inbred C57BL/6JNarl mice. Scramble IDO shRNA (Scr IDOsh), IDO shRNA (IDO sh), and 1-methyl-D-tryptophan (D-1MT) was treated on 7 days after LLC1 injection. ( b ) Tumor growth curve. *A statistically significant difference when compared with scramble IDO shRNA group on 16 days after LLC1 injection ( P < 0.05). ( c ) Number of tumor-infiltrated CD11b + Ly6G + neutrophils. *A statistically significant difference when compared with scramble IDO shRNA group ( P < 0.05). ( d ) Number of CD11b + Ly6G + neutrophils in spleen at 16 days after LLC1 injection. IDO, Indoleamine 2,3-dioxygenase; shRNA, short hairpin RNA.
B16 F1, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/b16-f1/product/ATCC
Average 97 stars, based on 1 article reviews
b16-f1 - by Bioz Stars, 2026-04
97/100 stars
  Buy from Supplier

Image Search Results


IDO shRNA and D-1MT treatment inhibits LLC1 tumor growth and causes increasing number of tumor-infiltrating neutrophils in a subcutaneous lung tumor model. ( a ) Experimental design. 2 × 10 5 LLC1 cells were subcutaneously injected into male inbred C57BL/6JNarl mice. Scramble IDO shRNA (Scr IDOsh), IDO shRNA (IDO sh), and 1-methyl-D-tryptophan (D-1MT) was treated on 7 days after LLC1 injection. ( b ) Tumor growth curve. *A statistically significant difference when compared with scramble IDO shRNA group on 16 days after LLC1 injection ( P < 0.05). ( c ) Number of tumor-infiltrated CD11b + Ly6G + neutrophils. *A statistically significant difference when compared with scramble IDO shRNA group ( P < 0.05). ( d ) Number of CD11b + Ly6G + neutrophils in spleen at 16 days after LLC1 injection. IDO, Indoleamine 2,3-dioxygenase; shRNA, short hairpin RNA.

Journal: Molecular Therapy. Nucleic Acids

Article Title: Neutrophils are Essential in Short Hairpin RNA of Indoleamine 2,3- Dioxygenase Mediated-antitumor Efficiency

doi: 10.1038/mtna.2016.105

Figure Lengend Snippet: IDO shRNA and D-1MT treatment inhibits LLC1 tumor growth and causes increasing number of tumor-infiltrating neutrophils in a subcutaneous lung tumor model. ( a ) Experimental design. 2 × 10 5 LLC1 cells were subcutaneously injected into male inbred C57BL/6JNarl mice. Scramble IDO shRNA (Scr IDOsh), IDO shRNA (IDO sh), and 1-methyl-D-tryptophan (D-1MT) was treated on 7 days after LLC1 injection. ( b ) Tumor growth curve. *A statistically significant difference when compared with scramble IDO shRNA group on 16 days after LLC1 injection ( P < 0.05). ( c ) Number of tumor-infiltrated CD11b + Ly6G + neutrophils. *A statistically significant difference when compared with scramble IDO shRNA group ( P < 0.05). ( d ) Number of CD11b + Ly6G + neutrophils in spleen at 16 days after LLC1 injection. IDO, Indoleamine 2,3-dioxygenase; shRNA, short hairpin RNA.

Article Snippet: Mouse Lewis lung carcinoma cell line, LLC1 (LL/2), was obtained from Bioresource Collection and Research Center (Hsinchu, Taiwan) and was maintained in Dulbecco's modified Eagle's medium (DMEM) (Lonza, Walkersville, MD) which was supplemented with 10% fetal bovine serum (FBS) and penicillin/streptomycin (100 U/0.1 mg/ml) (Life Technologies, Grand Island, NY).

Techniques: shRNA, Injection

IDO shRNA and D-1MT treatment induced Th1-bias immune responses. Spleens were collected at 16 days after LLC1 injection. Splenocytes and culture medium were collected after 24 hours culture. ( a ) mRNA expression of IDO. ( b ) mRNA expression of IFN-γ and IL-10. ( c ) Cytokines concentration of IFN-γ, TNF-α, IL-4 and IL-10. * or **A statistically significant difference when compared with scramble IDO shRNA group (* P < 0.05; ** P < 0.01). D-1MT, 1-methyl-D-tryptophan; IDO, Indoleamine 2,3-dioxygenase; IFN-γ, interferon- γ; IL-4, interlukein-4; shRNA, short hairpin RNA; TNF-α, tumor necrosis factor- α.

Journal: Molecular Therapy. Nucleic Acids

Article Title: Neutrophils are Essential in Short Hairpin RNA of Indoleamine 2,3- Dioxygenase Mediated-antitumor Efficiency

doi: 10.1038/mtna.2016.105

Figure Lengend Snippet: IDO shRNA and D-1MT treatment induced Th1-bias immune responses. Spleens were collected at 16 days after LLC1 injection. Splenocytes and culture medium were collected after 24 hours culture. ( a ) mRNA expression of IDO. ( b ) mRNA expression of IFN-γ and IL-10. ( c ) Cytokines concentration of IFN-γ, TNF-α, IL-4 and IL-10. * or **A statistically significant difference when compared with scramble IDO shRNA group (* P < 0.05; ** P < 0.01). D-1MT, 1-methyl-D-tryptophan; IDO, Indoleamine 2,3-dioxygenase; IFN-γ, interferon- γ; IL-4, interlukein-4; shRNA, short hairpin RNA; TNF-α, tumor necrosis factor- α.

Article Snippet: Mouse Lewis lung carcinoma cell line, LLC1 (LL/2), was obtained from Bioresource Collection and Research Center (Hsinchu, Taiwan) and was maintained in Dulbecco's modified Eagle's medium (DMEM) (Lonza, Walkersville, MD) which was supplemented with 10% fetal bovine serum (FBS) and penicillin/streptomycin (100 U/0.1 mg/ml) (Life Technologies, Grand Island, NY).

Techniques: shRNA, Injection, Expressing, Concentration Assay

IDO shRNA and D-1MT did not significantly affect the CD4 + CD25 + regulatory T cells. ( a ) Spleens were collected at 16 days after LLC1 injection and the population of CD4 + CD25 + Treg cells were determined on a flow cytometry. Data are the representative of at least three independent experiments. ( b ) The quantitative results. D-1MT, 1-methyl-D-tryptophan; IDO, Indoleamine 2,3-dioxygenase; shRNA, short hairpin RNA.

Journal: Molecular Therapy. Nucleic Acids

Article Title: Neutrophils are Essential in Short Hairpin RNA of Indoleamine 2,3- Dioxygenase Mediated-antitumor Efficiency

doi: 10.1038/mtna.2016.105

Figure Lengend Snippet: IDO shRNA and D-1MT did not significantly affect the CD4 + CD25 + regulatory T cells. ( a ) Spleens were collected at 16 days after LLC1 injection and the population of CD4 + CD25 + Treg cells were determined on a flow cytometry. Data are the representative of at least three independent experiments. ( b ) The quantitative results. D-1MT, 1-methyl-D-tryptophan; IDO, Indoleamine 2,3-dioxygenase; shRNA, short hairpin RNA.

Article Snippet: Mouse Lewis lung carcinoma cell line, LLC1 (LL/2), was obtained from Bioresource Collection and Research Center (Hsinchu, Taiwan) and was maintained in Dulbecco's modified Eagle's medium (DMEM) (Lonza, Walkersville, MD) which was supplemented with 10% fetal bovine serum (FBS) and penicillin/streptomycin (100 U/0.1 mg/ml) (Life Technologies, Grand Island, NY).

Techniques: shRNA, Injection, Flow Cytometry

The level of tryptophan transfer RNA was induced by IDO shRNA treatment in total splenocytes. Total splenocytes were collected at 16 days after LLC1 injection. The levels of tryptophan transfer RNA (tRNA Trp ) and initiator methionine transfer RNA (tRNA i Met ) was measured. *A statistically significant difference when compared with scramble IDO shRNA group (* P < 0.05). IDO, Indoleamine 2,3-dioxygenase; shRNA, short hairpin RNA.

Journal: Molecular Therapy. Nucleic Acids

Article Title: Neutrophils are Essential in Short Hairpin RNA of Indoleamine 2,3- Dioxygenase Mediated-antitumor Efficiency

doi: 10.1038/mtna.2016.105

Figure Lengend Snippet: The level of tryptophan transfer RNA was induced by IDO shRNA treatment in total splenocytes. Total splenocytes were collected at 16 days after LLC1 injection. The levels of tryptophan transfer RNA (tRNA Trp ) and initiator methionine transfer RNA (tRNA i Met ) was measured. *A statistically significant difference when compared with scramble IDO shRNA group (* P < 0.05). IDO, Indoleamine 2,3-dioxygenase; shRNA, short hairpin RNA.

Article Snippet: Mouse Lewis lung carcinoma cell line, LLC1 (LL/2), was obtained from Bioresource Collection and Research Center (Hsinchu, Taiwan) and was maintained in Dulbecco's modified Eagle's medium (DMEM) (Lonza, Walkersville, MD) which was supplemented with 10% fetal bovine serum (FBS) and penicillin/streptomycin (100 U/0.1 mg/ml) (Life Technologies, Grand Island, NY).

Techniques: shRNA, Injection

Tumor-infiltrating CD11b + Ly6G + neutrophils expressed high level of TNF- α and TGF- β in IDO shRNA treated mice. ( a ) Enriched CD11b + Ly6G + neutrophils from tumor-infiltrated cells. ( b ) The mRNA expression of tumor-infiltrating neutrophils which was collected on day 16 post LLC1 injection. ( c ) Tumor volume at day 23. ( d ) The mRNA expression of tumor-infiltrating neutrophils which was collected at day 23 post LLC1 injection. * or **A statistically significant difference when compared with scramble IDO shRNA group (* P < 0.05; ** P < 0.01). IDO, Indoleamine 2,3-dioxygenase; shRNA, short hairpin RNA; TGF-β, Transforming growth factor-β. TNF-α, tumor necrosis factor-α.

Journal: Molecular Therapy. Nucleic Acids

Article Title: Neutrophils are Essential in Short Hairpin RNA of Indoleamine 2,3- Dioxygenase Mediated-antitumor Efficiency

doi: 10.1038/mtna.2016.105

Figure Lengend Snippet: Tumor-infiltrating CD11b + Ly6G + neutrophils expressed high level of TNF- α and TGF- β in IDO shRNA treated mice. ( a ) Enriched CD11b + Ly6G + neutrophils from tumor-infiltrated cells. ( b ) The mRNA expression of tumor-infiltrating neutrophils which was collected on day 16 post LLC1 injection. ( c ) Tumor volume at day 23. ( d ) The mRNA expression of tumor-infiltrating neutrophils which was collected at day 23 post LLC1 injection. * or **A statistically significant difference when compared with scramble IDO shRNA group (* P < 0.05; ** P < 0.01). IDO, Indoleamine 2,3-dioxygenase; shRNA, short hairpin RNA; TGF-β, Transforming growth factor-β. TNF-α, tumor necrosis factor-α.

Article Snippet: Mouse Lewis lung carcinoma cell line, LLC1 (LL/2), was obtained from Bioresource Collection and Research Center (Hsinchu, Taiwan) and was maintained in Dulbecco's modified Eagle's medium (DMEM) (Lonza, Walkersville, MD) which was supplemented with 10% fetal bovine serum (FBS) and penicillin/streptomycin (100 U/0.1 mg/ml) (Life Technologies, Grand Island, NY).

Techniques: shRNA, Expressing, Injection

Neutrophils depletion abolished the antitumor effect of IDO shRNA. ( a ) Experimental design. 300 µg of anti-Ly6G antibody or IgG control was intraperitoneally injected at day 7, 10, and 14 after LLC1 cells injection. All mice were sacrificed at day 17. ( b ) Evaluation of depletion efficiency. The Ly6G + cells were detected in total splenocytes after injection of depletion antibodies. ( c ) Tumor volume was measured at day 17. *A statistically significant difference between IgG and Ly6G groups (* P < 0.05). IDO, Indoleamine 2,3-dioxygenase; IgG, immunoglobulin G; shRNA, short hairpin RNA.

Journal: Molecular Therapy. Nucleic Acids

Article Title: Neutrophils are Essential in Short Hairpin RNA of Indoleamine 2,3- Dioxygenase Mediated-antitumor Efficiency

doi: 10.1038/mtna.2016.105

Figure Lengend Snippet: Neutrophils depletion abolished the antitumor effect of IDO shRNA. ( a ) Experimental design. 300 µg of anti-Ly6G antibody or IgG control was intraperitoneally injected at day 7, 10, and 14 after LLC1 cells injection. All mice were sacrificed at day 17. ( b ) Evaluation of depletion efficiency. The Ly6G + cells were detected in total splenocytes after injection of depletion antibodies. ( c ) Tumor volume was measured at day 17. *A statistically significant difference between IgG and Ly6G groups (* P < 0.05). IDO, Indoleamine 2,3-dioxygenase; IgG, immunoglobulin G; shRNA, short hairpin RNA.

Article Snippet: Mouse Lewis lung carcinoma cell line, LLC1 (LL/2), was obtained from Bioresource Collection and Research Center (Hsinchu, Taiwan) and was maintained in Dulbecco's modified Eagle's medium (DMEM) (Lonza, Walkersville, MD) which was supplemented with 10% fetal bovine serum (FBS) and penicillin/streptomycin (100 U/0.1 mg/ml) (Life Technologies, Grand Island, NY).

Techniques: shRNA, Control, Injection